An Open-label Drug-drug Interaction Study in Healthy Female Adult Subjects to Investigate the Effect of Multiple Oral Doses of JNJ-42847922 on the Steady-state Pharmacokinetics of an Oral Contraceptive Containing Ethinyl Estradiol and Levonorgestrel
Phase of Trial: Phase I
Latest Information Update: 18 Sep 2017
At a glance
- Drugs Seltorexant (Primary) ; Ethinylestradiol/levonorgestrel
- Indications Insomnia; Major depressive disorder
- Focus Pharmacodynamics
- Sponsors Janssen-Cilag
- 13 Sep 2017 Planned End Date changed from 15 Nov 2017 to 8 Nov 2017.
- 13 Sep 2017 Planned primary completion date changed from 15 Nov 2017 to 8 Nov 2017.
- 13 Sep 2017 Status changed from not yet recruiting to recruiting.